Table 1.
Clinical Characteristics of Participants (n=393)
| Adduct Sample n=393 |
|
|---|---|
| n(%) | |
| Age (years) | |
| < 1 | 79(20.1) |
| 1–2 | 57(14.5) |
| 3–9 | 103(26.2) |
| 10–17 | 154(39.2) |
| Gender | |
| Male | 192(48.9) |
| Female | 201(51.1) |
| Race | |
| White | 295(76.0) |
| African American | 55(14.2) |
| Other | 38(9.8) |
| Unknown | 5 |
| Final Diagnosis | |
| Acetaminophen Toxicity | 58(14.8) |
| Metabolic | 27(6.9) |
| Autoimmune | 29(7.4) |
| Infection | 26(6.6) |
| Indeterminate | 190(48.4) |
| Other* | 63(16.0) |
| Outcome at 21 days | |
| Death without transplantation | 44(11.2) |
| Transplantation | 115(29.3) |
| Spontaneous Survival | 234(59.5) |
Common other diagnoses included hemophagocytic syndrome (5), shock/ischemia (8), neonatal iron storage (10), non-acetaminophen drug induced (13), and venoocclusive disease (5).